Clinical Trial

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A Phase 1/2a First-in-Human Study of DB-1419 in Advanced/Metastatic Solid Tumors
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-08-14; most recent amendment 2026-06-04.
Status change: Not Yet Recruiting → Recruiting 2024-09-17
Trial Details
NCT Number NCT06554795
Lead Sponsor DualityBio Inc.
Conditions Solid Tumor, Adult
Enrollment 360 participants
Start Date 2024-09-03
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-05